SCHEDULE: Morgan Stanley Cuts Artivion Stake Below 5%

Morgan Stanley has reduced its beneficial ownership in Artivion, Inc. to 4.4% of common stock, falling below the 5% reporting threshold.

Summary

• Morgan Stanley, a Delaware-organized entity, has filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership in Artivion, Inc.
• As of September 30, 2025, Morgan Stanley beneficially owns 2,074,975 shares of Artivion's Common Stock.
• This represents 4.4% of the class of securities, indicating a reduction from a previous holding above 5%.
• Morgan Stanley holds shared voting power over 208,344 shares and shared dispositive power over 2,074,975 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Artivion.

Sentiment

Score: 4

Explanation: The filing indicates a reduction in a significant institutional investor's stake, which is generally perceived as a negative signal for the issuer, although the filing itself is a routine regulatory disclosure without explicit negative commentary.

Negatives

• Morgan Stanley has reduced its beneficial ownership in Artivion, Inc. to below 5% of the common stock, potentially signaling a decrease in institutional confidence or a portfolio rebalancing.

Risks

• The reduction in a significant institutional investor's stake could lead to increased selling pressure on Artivion's stock.
• A decrease in institutional ownership might be perceived negatively by other investors, potentially impacting investor sentiment.

Future Outlook

NA

Industry Context

Schedule 13G filings are routine disclosures by institutional investors when their beneficial ownership of a company's stock crosses certain thresholds. A reduction below the 5% threshold, as seen here, indicates a significant portfolio adjustment by a major financial institution like Morgan Stanley, which can sometimes influence market perception of the issuer.

Stakeholder Impact

• Shareholders: May react negatively to the news of a major institutional investor reducing its stake, potentially leading to selling pressure.
• Potential Investors: Might view the reduction as a signal to reconsider investment in Artivion.

Key Dates

Keywords

Artivion Inc., Morgan Stanley, Schedule 13G, beneficial ownership, common stock, institutional ownership, SEC filing, equity stake